Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis

Objectives To investigate the cost effectiveness of cyclo-oxygenase-2 (COX 2) selective inhibitors and traditional non-steroidal anti-inflammatory drugs (NSAIDs), and the addition of proton pump inhibitors to these treatments, for people with osteoarthritis.Design An economic evaluation using a Mark...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ 2009-07, Vol.339 (jul14 1), p.b2538-b2538
Hauptverfasser:	Latimer, Nicholas, Lord, Joanne, Grant, Robert L, O’Mahony, Rachel, Dickson, John, Conaghan, Philip G
Format:	Artikel
Sprache:	eng
Schlagworte:	Analgesics Anti-Inflammatory Agents, Non-Steroidal - economics Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Biological Agents Cardiovascular Diseases - chemically induced Clinical Trials (Epidemiology) Cost-Benefit Analysis Cyclooxygenase 2 Inhibitors - economics Cyclooxygenase 2 Inhibitors - therapeutic use Degenerative Joint Disease Drug Therapy, Combination Drugs: Cardiovascular System Drugs: Musculoskeletal and Joint Diseases Gastrointestinal Diseases - chemically induced Health Economics Health Policy Health Service Research Heart attacks Heart failure Humans Ischaemic Heart Disease Musculoskeletal Syndromes Neurogastroenterology Nonsteroidal anti-inflammatory drugs Osteoarthritis Osteoarthritis - drug therapy Osteoarthritis - economics Proton Pump Inhibitors - economics Proton Pump Inhibitors - therapeutic use Protons Quality-Adjusted Life Years Randomized Controlled Trials as Topic Rheumatoid arthritis Stroke Ulcers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!